VivoSeq
Other

Third Molar

1

Pipeline Programs↗

5

Active Trials↗

5

Companies Involved↗

Third Molar is an early-stage landscape with 1 program across 5 companies. The most active players are MBD MARKETING SDN. BHD., Pfizer, Unither Pharmaceuticals, France.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

MBD MARKETING SDN. BHD.

2 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalU

Unither Pharmaceuticals, France

0 programs

PreclinicalMenarini logo

Menarini

0 programs

PreclinicalP

Purdue Pharma LP

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical1

ORAL7® Mouthwash

MBD MARKETING SDN. BHD.

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

35

clinical trials

Completed25 · 71%
Not yet recruiting4 · 11%
Unknown status3 · 9%
Recruiting1 · 3%
Terminated1 · 3%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

35 trials

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
Recruiting·AArcato Laboratories, Inc.·Phase 1·NCT06864884·30 enrolled
Autologous Dentine Graft Compared to Xenograft in Managing Periodontally Compromised Second Molar After Third Molar Removal
Not yet recruiting·NNational University of Malaysia·N/A·NCT07362394·34 enrolled
Periodontal Regeneration at the Distal Site of Second Molars After the Extraction of Lower Included Third Molars
Not yet recruiting·UUniversidad Complutense de Madrid·Phase 4·NCT07059247·24 enrolled
Lidocaine Patch and Lower Third Molar
Not yet recruiting·FFayoum University·Phase 3·NCT07330726·21 enrolled
Local Metformin Gel and Impacted Lower Third Molar
Not yet recruiting·FFayoum University·Phase 2·NCT06975839·36 enrolled
Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction
Completed·UUnither Pharmaceuticals, France·Phase 3·NCT04622735·321 enrolled
Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction
Completed·GGrünenthal GmbH·Phase 3·NCT03714672·1,151 enrolled
Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars
Completed·RReckitt Benckiser Healthcare (UK) Limited·Phase 3·NCT05484401·294 enrolled
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Completed·Pfizer logoPfizer·Phase 2·NCT00663767·250 enrolled
Effect of High-dose Naloxone Following Third Molar Extraction
Completed·—·Phase 2·NCT02976337·23 enrolled
The Impact of Arnica Montana Following the Surgical Extraction of Impacted Third Molars
Completed·SSaint-Joseph University·N/A·NCT06193720·10 enrolled
Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal
Completed·—·Phase 4·NCT02730026·50 enrolled
Fixed-dose Combination of Oxycodone [OXIcodona] + IbuproFEN in Pain Relief After Third Molar Extraction
Completed·EEurofarma Laboratorios S.A.·Phase 3·NCT05081102·288 enrolled
Capsaicin to Control Pain Following Third Molar Extraction
Completed·National Institute of Dental and Craniofacial Research (NIDCR)·Phase 2·NCT00088686·75 enrolled
Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal
Completed·—·Phase 4·NCT02494856·50 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)